Product
Vietnam·Risk Class TTBYT Loại B·TCCS-13B:2023/CPC1HN·CPC1 Pharmaceutical Corporation, Hanoi·Registered Oct 19, 2023- Analysis ID
- 230002714/PCBB-HN
- Submission ID
- 000.00.19.H26-231005-0013
- Product Type
- TCCS-13B:2023/CPC1HN
- Manufacturer
- CPC1 Pharmaceutical Corporation, Hanoi
- Intended Use
- - Supports the treatment of folliculitis, quickly drying up the acne cysts, and preventing and reducing any abnormalities that may occur during the process of keratinization. - Stimulates the process of exfoliation of the keratinized layers of the skin, accelerating the treatment process for acne. - Rebuilds the damaged skin area caused by folliculitis, replenishing the skin with nutrients to make it smooth and prevent scarring in the damaged skin areas. - The condition of folliculitis will improve within 1-2 weeks. It is recommended to use continuously for 4-8 weeks to achieve the best results.
- Registration Date
- Oct 19, 2023
Companies providing products similar to "Product"
Recently registered similar products
Access comprehensive regulatory information for Product in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại B medical device is registered under number 230002714/PCBB-HN and manufactured by CPC1 Pharmaceutical Corporation, Hanoi.
This page provides complete technical specifications, regulatory compliance details, 5 companies making similar products including MetaSystems Probes GmbH, Fujifilm Irvine Scientific, Inc, and 5 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.